US clinical-stage biopharmaceutical company Seaport Therapeutics has closed a US$100 million oversubscribed Series A financing round to progress a pipeline using a platform developed at the Monash Institute of Pharmaceutical Sciences. …
Seaport Therapeutics receives $100 million in funding to maximise Monash invention
April 15, 2024 Australian Biotech
Latest Video
New Stories
-
Summit's day one provided critical lessons for both sides of the Tasman
April 30, 2024 - - Latest News -
'Important for me to share the full picture as we must never allow it to happen again'
April 30, 2024 - - Latest News -
NZ Government commits new funding to address Pharmac's 'fiscal cliff'
April 29, 2024 - - Latest News -
NZ Government appoints former Deputy PM new chair of Pharmac
April 29, 2024 - - Latest News -
The listing will 'benefit thousands of Australian women', says Mark Butler
April 29, 2024 - - Latest News -
'An important first step to achieving reimbursed access for eligible patients in Australia'
April 28, 2024 - - Latest News -
The 'Week in Review' Podcast - 26 April
April 28, 2024 - - Podcast